PF-07242813 / Pfizer - LARVOL DELTA

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis (clinicaltrials.gov) - P1 | N=122 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed

Trial completion • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis (clinicaltrials.gov) - P1 | N=104 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting

Enrollment closed • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis (clinicaltrials.gov) - P1 | N=145 | Recruiting | Sponsor: Pfizer | Trial completion date: Nov 2021 ➔ Oct 2022 | Trial primary completion date: Nov 2021 ➔ Oct 2022

Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis (clinicaltrials.gov) - P1; N=146; Recruiting; Sponsor: Pfizer; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis (clinicaltrials.gov) - P1; N=145; Not yet recruiting; Sponsor: Pfizer

Clinical • New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology